Insider Trading Stories

Filed transaction by LUCKY STRIKE ENTERTAINMENT Director, Officer: Executive Vice Chairman. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Disposition of 4079120 stock option (right to buy) at 7.92 of LUCKY STRIKE by Parker Brett I. on 13th of January 2025. This event was filed by LUCKY STRIKE ENTERTAINMENT with SEC on 2025-01-13. Statement of changes in beneficial ownership - SEC Form 4  
LUCKY STRIKE ENTERTA
  39 minutes ago at Macroaxis
Filed for Parker Brett I.
Filed transaction by LIONS GATE ENTERTAINMENT Director, Officer: Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). LIONS insider trading alert for disposition of class b common shares by Feltheimer Jon, Director, Officer: Chief Executive Officer, on 31st of December 2024. This event was filed by LIONS GATE ENTERTAINMENT with SEC on 2024-12-31. Statement of changes in beneficial ownership - SEC Form 4  
LIONS GATE ENTERTAINMENT
  46 minutes ago at Macroaxis
Filed for Feltheimer Jon
Filed transaction by Horizon Kinetics SPAC Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3. Horizon insider trading alert for disposition of class b common stock by Wilson Jan C., Director, on 17th of January 2025. This event was filed by Horizon Kinetics SPAC with SEC on 2022-03-16. Statement of changes in beneficial ownership - SEC Form 4  
Horizon Kinetics SPAC
  few hours ago at Macroaxis
Filed for Wilson Jan C.
Filed transaction by Customers Bancorp Officer: Cfo Customers Bank. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Disposition of 20000 stock options (right to buy) at 28.37 of Customers Bancorp by Watkins Philip on 17th of January 2025. This event was filed by Customers Bancorp with SEC on 2026-02-24. Initial filing of beneficial ownership - SEC Form 3  
Customers Bancorp
  few hours ago at Macroaxis
Filed for Watkins Philip
Filed transaction by Hawthorn Bancshares Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3. Disposition of 1817 common stock at 32.21 of Hawthorn Bancshares by Holtaway Jonathan on 17th of January 2025. This event was filed by Hawthorn Bancshares with SEC on 2024-12-04. Statement of changes in beneficial ownership - SEC Form 4  
Hawthorn Bancshares
  few hours ago at Macroaxis
Filed for Holtaway Jonathan
Filed transaction by Vera Therapeutics Director, Officer: President And Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Disposition of 9975 class a common stock at 41.5335 of Vera Therapeutics by Fordyce Marshall on 8th of January 2025. This event was filed by Vera Therapeutics with SEC on 2025-01-08. Statement of changes in beneficial ownership - SEC Form 4  
Vera Therapeutics
  few hours ago at Macroaxis
Filed for Fordyce Marshall
Filed transaction by Alaunos Therapeutics Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Disposition of 818 common stock at 2.0 of Alaunos Therapeutics by Vieser Jaime on 31st of December 2024. This event was filed by Alaunos Therapeutics with SEC on 2024-12-31. Statement of changes in beneficial ownership - SEC Form 4  
Alaunos Therapeutics
  few hours ago at Macroaxis
Filed for Vieser Jaime
Filed transaction by PEDEVCO Corp Officer: Chief Commercial Officer. Insider Public Trading. PEDEVCO insider trading alert for general transaction of common stock by Crook Jody D., Officer: Chief Commercial Officer, on 1st of January 2025. This event was filed by PEDEVCO Corp with SEC on 2025-01-01. Initial filing of beneficial ownership - SEC Form 3  
PEDEVCO Corp
  few hours ago at Macroaxis
Filed for Crook Jody D.
Filed transaction by Regulus Therapeutics Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Disposition of 5088 common stock at 1.2632 of Regulus Therapeutics by Calsada Crispina on 14th of January 2025. This event was filed by Regulus Therapeutics with SEC on 2025-01-14. Statement of changes in beneficial ownership - SEC Form 4  
Regulus Therapeutics
  few hours ago at Macroaxis
Filed for Calsada Crispina